Clinical Trials in New York

Showing 8381-8400 of 17,259 trials

RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMAS

NCT00126672

This research study is evaluating a drug called rapamycin as a possible treatment for the lumps (or tumors) that form in the kidneys, called angiomyolipomas, in people who have either TSC or LAM. Kidney angiomyolipomas are tumors that are made up of blood vessels, muscle and fat. Rapamycin has been approved to treat other diseases, but it is investigational for treating kidney angiomyolipomas. Investigational means that it is being as a possible treatment for kidney angiomyolipomas but is not currently approved by the U.S. Food and Drug Administration (FDA) for treating this disease.

Nonmalignant NeoplasmTuberous SclerosisLymphangioleimyomatosis+1 more

Dana-Farber Cancer Institute36 participantsStarted Dec 2005

Loma Linda, California, United States • Hartford, Connecticut, United States • Boston, Massachusetts, United States +4 more locations

COMPLETEDPhase 4< 1 mile

Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)

NCT02519777

People infected with HIV often have cognitive dysfunction even if they are on antiretroviral therapy (ART) and have undetectable viral loads. The study evaluated if the addition of maraviroc (MVC) and dolutegravir (DTG) (which are two antiretroviral \[ARV\] medications) to participants' existing ART regimens improved participants' neurocognitive performance.

HIV Infections

National Institute of Allergy and Infectious Diseases (NIAID)191 participantsStarted Apr 2016

Los Angeles, California, United States • San Diego, California, United States • Torrance, California, United States +27 more locations

RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMAS

Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)

Find Trials by Condition in New York

A Study to Compare BMS-936558 to the Physician's Choice of Either Dacarbazine or Carboplatin and Paclitaxel in Advanced Melanoma Patients That Have Progressed Following Anti-CTLA-4 Therapy (CheckMate 037)

An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials

The Product Surveillance Registry REVERSE Post Approval Study

Safety, Tolerability, and Sustained Weight Loss of Endoscopic Sleeve Gastroplasty With Diet Modification and Exercise

Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease

Compare Efficacy/Safety of Repeat Doses of Ferumoxytol With Iron Sucrose in CKD Subjects With IDA and on Hemodialysis

Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI

Evaluating the Infectivity, Safety, and Immunogenicity of Recombinant Live-Attenuated RSV Vaccines RSV ΔNS2/Δ1313/I1314L or RSV 276 in RSV-Seronegative Infants 6 to 24 Months of Age

Coronary Artery Calcification Score and Risk Factors for Coronary Artery Disease in Persons With Spinal Cord Injury

CO2 Laser vs Lidocaine for Vestibulodynia in Premenopausal Women

Supported Employment Demonstration

Conservative Treatment of Mallet Finger Injury

Study of Durvalumab (MEDI4736) After Chemo-Radiation for Microsatellite Stable Stage II-IV Rectal Cancer

A Phase 1b Study of IV PRM151 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

A Safety, Tolerability, and Pharmacokinetics Study of a Single Intravenous Injection of Recombinant Coagulation Factor VIII Fc - Von Willebrand Factor - XTEN Fusion Protein (rFVIIIFc-VWF-XTEN) (BIVV001) in Previously Treated Adults With Severe Hemophilia A (EXTEN-A)

Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer

Rollover Study for Continuing NBI-98854 Administration in Pediatric Subjects With Tourette Syndrome

Revealed Versus Concealed Cerebroplacental Ratio